May measurement month 2017: Latin America.


Journal

Journal of hypertension
ISSN: 1473-5598
Titre abrégé: J Hypertens
Pays: Netherlands
ID NLM: 8306882

Informations de publication

Date de publication:
06 2020
Historique:
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 14 5 2021
Statut: ppublish

Résumé

To raise awareness of blood pressure, measured by number of countries involved, number of people screened, and number of people who have untreated or inadequately treated hypertension. An opportunistic cross-sectional survey of volunteers aged at least 18 years was carried out in May 2017. Blood pressure measurement, the definition of hypertension and statistical analysis followed the standard May measurement month protocol. Eighteen countries in Latin America and the Caribbean participated in the campaign, providing us with a wide sample for characterization. During May measurement month 2017 in Latin America and the Caribbean, 105 246 individuals were screened. Participants who had cardiovascular disease, 2245 (2.3%) had a prior myocardial infarction, and 1711 (1.6%) a previous stroke, additionally 6760 (6.4%) individuals were diabetic, 7014 (6.7%) current smokers and 9262 (8.8%) reported alcohol intake once or more per week. Mean SBP was 122.7 mmHg and DBP was 75.6 mmHg. After imputation, 42 328 participants (40,4%) were found to be hypertensive. The high numbers of participants detected with hypertension and the relatively large proportion of participants on antihypertensive treatment but with uncontrolled hypertension reinforces the importance of this annual event in our continent, to raise awareness of the prevention of cardiovascular events.

Identifiants

pubmed: 32371809
doi: 10.1097/HJH.0000000000002370
pii: 00004872-202006000-00024
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1183-1188

Références

Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health 2018; 6:e736–e743.
Turnbull F, Woodward M, Neal B, Barzi F, Ninomiya T, Chalmers J, et al. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J 2008; 29:2669–2680.
Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, et al. A call to action and a life-course strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016; 388:2287–2712.
Ribeiro AL, Duncan BB, Brant LC, Lotufo PA, Mill JG, Barreto SM. Cardiovascular health in Brazil: trends and perspectives. Circulation 2016; 133:422–433.
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high, middle, and low-income countries. JAMA 2013; 310:959–968.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation 2016; 134:441–450.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 2017; 390:2549–2558.
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015. JAMA 2017; 317:165–182.
Maimaris W, Paty J, Perel P, Legido-Quigley H, Balabanova D, Nieuwlaat R, et al. The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review. PLoS Med 2013; 10:e1001490.
Hernández-Hernández R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J, et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hypertens 2010; 28:24–34.
Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Ayçaguer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008; 121:58–65.
Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S. PURE Investigators-Writing GroupThe Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158:1–7.

Auteurs

Eduardo C D Barbosa (ECD)

Department Hypertension, Brazilian Society Cardiology, FUNCOR, Liga de Hipertensão de Porto Alegre, Porto Alegre, Brazil.

Agustin Ramirez (A)

Arterial Hypertension and Metabolic Unit, University Hospital, Fundación Favaloro, Caba, Argentina.

Thomas Beaney (T)

Imperial College London, London, UK.

Elsa Kobeissi (E)

Imperial College London, London, UK.

Patricio Lopez-Jaramillo (P)

Fundación Oftalmológica de Santander (FOSCAL) Medical School, UDES, Bucaramanga, Colombia.

Rafael Hernánez-Hernández (R)

Clinical Pharmacology Unit, Hypertension and Cardiovascular RiskFactorsClinic, Universidad Centro Occidental Lisandro Alvarado, Barquisimeto, Venezuela.

Bruna Eibel (B)

Post Graduate Program Institute of Cardiology RGS, Porto Alegre, Brazil.

Fernando Lanas (F)

Universidad de La Frontera, Temuco, Chile.

Ernesto Penaherrera (E)

Del Servicio de Cardiología Hospital Luis Vernaza, Guayaquil, Ecuador.

Marcos Marin (M)

Argentinian Society of Hypertension, Buenos Aires, Argentina.

José Boggia (J)

Centro de Nefrologia, Hospital Manuel Quintela, Universidad de la Republica, Montevideo, Uruguay.

Jose Ortellado (J)

Centro de Nefrologia, Hospital Manuel Quintela, Universidad de la Republica, Montevideo, Uruguay.

Enrique Gomez (E)

Centro de Nefrologia, Hospital Manuel Quintela, Universidad de la Republica, Montevideo, Uruguay.

Enrique Sánchez (E)

Hospital Vivian Pellas, Managua, Managua, Nicaragua.

Alfonso Bryce (A)

Hospital Vivian Pellas, Managua, Managua, Nicaragua.

Osiris Valdez (O)

Dpto de Cardiologia Hospital Central Romana, La Romana, Dominican Republic.

Holly Beistline (H)

Operation Blessing International, Virginia Beach, Virginia, USA.

Chukwuemeka Nwokocha (C)

Department of Basic Medical Sciences, University of The West Indies, Mona Campus, Jamaica.

Kenneth Connell (K)

The University of the West Indies - Cave Hill Campus, Wanstead, Barbados.

Ana Barrientos (A)

The University of the West Indies - Cave Hill Campus, Wanstead, Barbados.

Fernando Wyss (F)

Technology and Cardiosvascular Service of Guatemala - Cardiosolutions, Guatemala City, Guatemala.

John Kenerson (J)

Department Hypertension, Brazilian Society Cardiology, FUNCOR, Liga de Hipertensão de Porto Alegre, Porto Alegre, Brazil.

Neil R Poulter (NR)

Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH